Bellwether Advisors, LLC Intellia Therapeutics, Inc. Transaction History

Bellwether Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $0 - $0	0 New	0 $0
Q2 2022 Aug 05, 2022	SELL	$38.49 - $76.21 $1,154 - $2,286	-30 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$100.76 - $138.36 $1.18 Million - $1.62 Million	-11,721 Reduced 99.74%	30 $3,000
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $1.56 Million - $2.08 Million	11,751 New	11,751 $1.58 Million
Q2 2021 Aug 10, 2021	SELL	$60.88 - $161.91 $4,383 - $11,657	-72 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$46.59 - $83.68 $372 - $669	-8 Reduced 10.0%	72 $5,000
Q4 2020 Jan 29, 2021	BUY	$18.83 - $63.53 $1,506 - $5,082	80 New	80 $4,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Bellwether Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellwether Advisors, LLC with notifications on news.